ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/oestrogen-axis

Search results

target/oestrogen-axis
45 trial(s) found.
NA
NA
NA
NA
2640 - Albury - Border Medical Oncology Research Unit (TERMINATED)
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (WITHDRAWN)
3280 - Warrnambool - South West Healthcare, Warrnambool Base Hospital, Oncology Unit (WITHDRAWN)
3844 - Traralgon - Latrobe Regional Hospital (WITHDRAWN)
SA5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (WITHDRAWN)
2485 - Tweed Heads - The Tweed Hospital (WITHDRAWN)
WA6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (WITHDRAWN)
2076 - Wahroonga - Sydney Adventist Hospital (WITHDRAWN)2228 - Miranda - Southside Cancer Care Centre (WITHDRAWN)
NSW2050 - Camperdown - Chris O'Brien Lifehouse (TERMINATED)
2076 - Wahroonga - Sydney Adventist Hospital (COMPLETED)2485 - Tweed Heads - The Tweed Hospital (COMPLETED)2640 - Albury - Border Medical Oncology Research Unit (COMPLETED)
3000 - Melbourne - Peter MacCallum Cancer Centre (COMPLETED)3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (COMPLETED)3165 - East Bentleigh - Peter MacCallum Cancer Centre Moorabbin Campus (COMPLETED)
QLD4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (COMPLETED)
Filters
oestrogen axis
100%
ER
71%
CDK4
58%
CDK6
51%
PI3Kalpha
24%
CDK4 selective
18%
androgen axis
16%
mTOR
13%
mTORC1
13%
CDK2
13%
AKT
9%
AR
9%
GnRH
9%
KAT6
7%
KAT6A
7%
ERBB2
7%
VEGF
7%
LHRH
7%
mTORC2
4%
PARP
4%
Trop2
4%
PD-1/PD-L1
4%
PD-L1
4%
CYP17A1
4%
PI3K
2%
Bcl2
2%
ER alpha
2%
PARP1-selective
2%
BRAF
2%
CRAF
2%
FAK
2%
MEK
2%
RAF
2%
PI3Kalpha H1047R
2%
CDK7
2%
ER
2%
CD40
2%
IL-6
2%
LIV1
2%
HMG-CoA reductase
2%
NA